In conclusion, we created 2 new obesity models, a hypomorphic highlighting species differences and an amorphic providing a preclinical model to test the therapeutic potential of PCs to treat MC4R-linked obesity. Here, MC4R is linked to obesity due to melanocortin 4 receptor deficiency.